Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nautilus Biotechnology Inc (NAUT)

Nautilus Biotechnology Inc (NAUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nautilus Biotechnology Inc 2701 EASTLAKE AVE EAST SEATTLE WA 98102 USA

www.nautilus.bio Employees: 155 P: 206-333-2001

Sector:

Medical

Description:

Nautilus Biotechnology Inc. is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus Biotechnology Inc., formerly known as Arya Sciences Acquisition Corp III, is based in SEATTLE.

Key Statistics

Overview:

Market Capitalization, $K 256,399
Enterprise Value, $K 228,749
Shares Outstanding, K 126,305
Float, K 74,394
% Float 58.90%
Short Interest, K 369
Short Float 0.29%
Days to Cover 1.57
Short Volume Ratio 0.14
% of Insider Shareholders 41.10%
% of Institutional Shareholders 50.71%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -70,780 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -13,570 K
EBIT, $ -71,390 K
EBITDA, $ -67,840 K

Growth:

1-Year Return 19.41%
3-Year Return 1.50%
5-Year Return -89.50%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.11 on 10/27/25
Next Earnings Date 02/26/26 [BMO]
Earnings Per Share ttm -0.50
EPS Growth vs. Prev Qtr 8.33%
EPS Growth vs. Prev Year 15.38%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NAUT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -33.35%
Return-on-Assets % -28.41%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.51
Book Value/Share 1.34
Interest Coverage -1.28
60-Month Beta 1.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar